GS-441524
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-441524, covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects [Phase 1]